PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
75.67%
Revenue growth above 1.5x RUN's 7.25%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
139.12%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
505.40%
Positive EBIT growth while RUN is negative. John Neff might see a substantial edge in operational management.
616.64%
Positive operating income growth while RUN is negative. John Neff might view this as a competitive edge in operations.
320.55%
Positive net income growth while RUN is negative. John Neff might see a big relative performance advantage.
329.17%
Positive EPS growth while RUN is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
315.00%
Positive diluted EPS growth while RUN is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.14%
Share change of 0.14% while RUN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-1.82%
Reduced diluted shares while RUN is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
477.41%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
156.59%
Positive FCF growth while RUN is negative. John Neff would see a strong competitive edge in net cash generation.
10938.99%
10Y CAGR of 10938.99% while RUN is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
53.87%
5Y CAGR of 53.87% while RUN is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
53.69%
3Y CAGR of 53.69% while RUN is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
4077.42%
OCF/share CAGR of 4077.42% while RUN is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-4.71%
Negative 5Y OCF/share CAGR while RUN is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-32.03%
Negative 3Y OCF/share CAGR while RUN stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
821.32%
10Y net income/share CAGR of 821.32% while RUN is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
10067.98%
Net income/share CAGR of 10067.98% while RUN is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
220.60%
3Y net income/share CAGR of 220.60% while RUN is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
-19.49%
Negative 5Y equity/share growth while RUN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-10.49%
Negative 3Y equity/share growth while RUN is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.06%
AR growth of 22.06% while RUN is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
6.77%
Inventory growth of 6.77% while RUN is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-1.43%
Negative asset growth while RUN invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
10.92%
BV/share growth of 10.92% while RUN is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
7.10%
Debt growth of 7.10% while RUN is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
31.43%
R&D growth drastically higher vs. RUN's 19.06%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.93%
SG&A growth well above RUN's 5.06%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.